DXA-Measured Visceral Fat Accelerates Biological Aging Independent of BMI in 4800 Middle-Aged Adults

The cross-sectional analysis of 4798 participants aged 45-69 from the Busselton cohort used DXA-derived visceral adipose tissue as the primary exposure and epigenetic clocks plus telomere length as outcomes. Associations persisted after multivariable adjustment, pointing to visceral fat's secretion of pro-inflammatory cytokines as a plausible mechanism beyond total adiposity. This observational design cannot establish causality but aligns with prior mechanistic work on adipose-derived inflammation and cellular senescence.

Context from related studies shows visceral fat correlates with higher IL-6 and CRP levels that drive epigenetic drift, while weight-loss trials reducing visceral fat by 15-20% have slowed Horvath clock progression by 1-2 years. The Busselton findings extend these patterns to population-level data with direct imaging rather than surrogate waist measures. Limitations include single-timepoint assessment and lack of longitudinal aging trajectories.

Next steps require randomized trials testing whether targeted visceral fat reduction via GLP-1 agonists or exercise alters epigenetic age over five years, with primary endpoints of GrimAge or DunedinPACE change exceeding 0.5 years per calendar year.